APOE832/rs405509 located in the putative promoter region has previously been shown to be associated with LDL-related traits (LDL-C, TC, and ApoB) [16]–[17], [45], APOE gene expression [46], myocardial infarction risk [47], and premature CHD [48]. This evidence concerns the gene APOE and myocardial infarction.